Jingmei Hsu

1.3k total citations
50 papers, 696 citations indexed

About

Jingmei Hsu is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Jingmei Hsu has authored 50 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 27 papers in Oncology and 11 papers in Genetics. Recurrent topics in Jingmei Hsu's work include Hematopoietic Stem Cell Transplantation (19 papers), CAR-T cell therapy research (13 papers) and Acute Myeloid Leukemia Research (9 papers). Jingmei Hsu is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), CAR-T cell therapy research (13 papers) and Acute Myeloid Leukemia Research (9 papers). Jingmei Hsu collaborates with scholars based in United States, Belgium and Egypt. Jingmei Hsu's co-authors include Brehon C. Laurent, Jian Huang, Yanique Rattigan, Debabrata Banerjee, John Glod, Pravin J. Mishra, Koen van Besien, Usama Gergis, Sebastian Mayer and Adrienne A. Phillips and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Jingmei Hsu

45 papers receiving 685 citations

Peers

Countries citing papers authored by Jingmei Hsu

Since Specialization

Citations

This map shows the geographic impact of Jingmei Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingmei Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingmei Hsu more than expected).

Fields of papers citing papers by Jingmei Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingmei Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingmei Hsu. The network helps show where Jingmei Hsu may publish in the future.

Co-authorship network of co-authors of Jingmei Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingmei Hsu. A scholar is included among the top collaborators of Jingmei Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingmei Hsu. Jingmei Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections 2024 ·Nature Communications ·Mohammed Nooruzzaman, (unknown), (unknown), Eli J. Finkelsztein, Leonardo C. Caserta, Rosy Priya Kodiyanplakkal, (unknown), Jingmei Hsu, (unknown), Stephanie Banakis, J. P. Albert, Lars F. Westblade, Claudio Zanettini, Luigi Marchionni, Rosemary Soave, Elodie Ghedin, Diego G. Diel, Mirella Salvatore	20
2	PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation 2023 ·Blood Advances ·A. Samer Al‐Homsi, (unknown), (unknown), (unknown), (unknown), Sharon L. Gardner, Jingmei Hsu, (unknown), Benedetto Bruno, Judith D. Goldberg, Benjamin Levinson, Maher Abdul‐Hay	17
3	Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid Leukemia 2022 ·Hematology/Oncology and Stem Cell Therapy ·Xia Bi, Jingmei Hsu, (unknown), (unknown), (unknown), Usama Gergis	2
4	Chimeric Antigen Receptor T-cell Therapies in Lymphoma Patients with Central Nervous System Involvement 2022 ·Hematology/Oncology and Stem Cell Therapy ·(unknown), (unknown), Ghada Elgohary, Jingmei Hsu, (unknown), (unknown), Usama Gergis	3
5	Allogeneic Chimeric Antigen Receptor T Cells for Hematologic Malignancies 2022 ·Hematology/Oncology and Stem Cell Therapy ·(unknown), Xia Bi, (unknown), (unknown), Jingmei Hsu, Usama Gergis	5
6	Next-Generation Chimeric Antigen Receptor T-cells 2022 ·Hematology/Oncology and Stem Cell Therapy ·(unknown), (unknown), Jingmei Hsu, (unknown), Xia Bi, Mahmoud Aljurf, Usama Gergis	6
7	Chimeric Antigen Receptor T Cell Therapy For Solid Tumors 2022 ·Hematology/Oncology and Stem Cell Therapy ·Jingmei Hsu, (unknown), (unknown), Xia Bi, (unknown), Usama Gergis	3
8	Cord blood transplants supported by unrelated donor CD34+ progenitor cells 2020 ·Bone Marrow Transplantation ·(unknown), (unknown), (unknown), Melissa M. Cushing, Usama Gergis, Jingmei Hsu, Yen‐Michael S. Hsu, Sebastian Mayer, Adrienne A. Phillips, (unknown), (unknown), Tsiporah B. Shore, Koen van Besien	5
9	High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma 2019 ·Bone Marrow Transplantation ·(unknown), Tomer M. Mark, (unknown), Paul J. Christos, Usama Gergis, (unknown), Jingmei Hsu, Sebastian Mayer, Rubén Niesvizky, Roger Pearse, Adrienne A. Phillips, Adriana Rossi, Morton Coleman, Koen van Besien, Tsiporah B. Shore	17
10	Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes 2018 ·Biology of Blood and Marrow Transplantation ·Usama Gergis, (unknown), Tsiporah B. Shore, Sebastian Mayer, Adrienne A. Phillips, Jingmei Hsu, Gail J. Roboz, Ellen K. Ritchie, Joseph M. Scandura, Sang‐Min Lee, Pinkal Desai, Michael S. Samuel, (unknown), (unknown), (unknown), (unknown), Ludy Dobrila, Andromachi Scaradavou, Koen van Besien	1
11	CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational Study 2018 ·Blood ·Jingmei Hsu, Marshall J. Glesby, Tsiporah B. Shore, Catherine B. Small, Usama Gergis, Sebastian Mayer, Adrienne A. Phillips, Lawrence D. Petz, Renee Browning, Meredith G. Warshaw, Deborah Persaud, (unknown), Koen van Besien	0
12	Chd7 deficiency delays leukemogenesis in mice induced by Cbfb-MYH11 2017 ·Blood ·Tao Zhen, Erika M. Kwon, Ling Zhao, Jingmei Hsu, R. Katherine Hyde, Ying Lu, Lemlem Alemu, Nancy A. Speck, Paul Liu	20
13	Kidney Dysfunction Post-Allogeneic Transplant: High Incidence of TMA and Kidney GvHD 2017 ·Blood ·Hannah Choe, (unknown), Usama Gergis, Tsiporah B. Shore, Sebastian Mayer, Jingmei Hsu, Adrienne A. Phillips, Surya V. Seshan, Thangamani Muthukumar, Koen van Besien	1
14	Safe and Effective Implementation of a Red Blood Cell (RBC) Transfusion Hemoglobin (Hb) Threshold of 7 g/Dl on an Inpatient Stem Cell Transplant Unit: A Single Institution Experience 2017 ·Blood ·Melissa M. Cushing, Ljiljana V. Vasović, Kathleen Kane, Usama Gergis, Adriana Rossi, Adrienne A. Phillips, Yen‐Michael S. Hsu, (unknown), Sebastian Mayer, Jingmei Hsu, Sang‐Min Lee, Tsiporah B. Shore, Koen van Besien, Ruchika Goel	1
15	Novel Risk Factors for Epstein-Barr Virus (EBV) Reactivation and Post-Transplant Lymphoproliferative Disorder (PTLD) after Allogeneic Hematopoietic Stem Cell Transplant 2017 ·Blood ·(unknown), Tsiporah B. Shore, Usama Gergis, Jingmei Hsu, Adrienne A. Phillips, Sebastian Mayer, Hanna Rennert, Koen van Besien	3
16	Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia 2017 ·Biology of Blood and Marrow Transplantation ·Jingmei Hsu, Andrew Artz, Sebastian Mayer, (unknown), Michael R. Bishop, Ronit Reich‐Slotky, Sonali M. Smith, (unknown), Justin Kline, (unknown), Adrienne A. Phillips, Usama Gergis, Hongtao Liu, Wendy Stock, Melissa M. Cushing, Tsiporah B. Shore, Koen van Besien	15
17	DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia 2015 ·Clinical Cancer Research ·Alison R. Sehgal, Phyllis A. Gimotty, Jianhua Zhao, Jingmei Hsu, Robert Daber, Jennifer D. Morrissette, Selina M. Luger, Alison W. Loren, Martin Carroll	39
18	Additional chromosomal abnormalities in core-binding factor acute myeloid leukemia 2015 ·Genetics and Molecular Research ·Hui‐Hua Hsiao, (unknown), (unknown), (unknown), Chuanfeng Wu, Shih‐Feng Cho, Jingmei Hsu, (unknown), (unknown), (unknown), Chia‐Wei Chang, (unknown), (unknown)	9
19	The RSC Nucleosome-Remodeling Complex Is Required for Cohesin's Association with Chromosome Arms 2004 ·Molecular Cell ·Jian Huang, Jingmei Hsu, Brehon C. Laurent	6
20	The RSC Nucleosome-Remodeling Complex Is Required for Cohesin's Association With Chromosome Arms 2004 ·Molecular Cell ·Jian Huang, Jingmei Hsu, Brehon C. Laurent	136

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact